OPKO Health (OPK) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.01
- EPS estimate
- −$0.08
- EPS surprise
- +87.50%
- Revenue surprise
- +24.59%
- Revenue
- $163.5M
- Revenue estimate
- $131.2M
- Reported
- Jul 27, 2026
OPKO Health reported Q2 2026 results on July 27, 2026. The company posted a loss of $0.01 per share, much narrower than the $0.08 loss expected, an 87.50% beat. Revenue was $163.5 million, 24.59% above the $131.2 million estimate. Compared with Q2 2025, the loss narrowed from $0.19 per share and revenue rose about 4% from $156.8 million.
OPKO has reported a loss in 16 of the 20 quarters in the table. The full-year loss was $0.44 per share in 2022, $0.25 in 2023, $0.09 in 2024 and $0.30 in 2025. Annual revenue fell from $1.0 billion in 2022 to $863.5 million in 2023, $713.1 million in 2024 and $606.9 million in 2025, about 40% below the 2022 level. Q1 2026 revenue of $124.2 million was the lowest quarter in the table, so Q2's figure was a rise of about 32% from the quarter before. Against estimates, the record is mixed: 11 beats, 8 misses and one in-line result over the last 20 quarters.
Q3 results came out between October 28 and November 8 in each of the past five years. That points to late October or early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 27, 2026 | −$0.08 | −$0.01 | +87.50% | $163.5M | SEC |
| Q1 2026 | Apr 28, 2026 | −$0.07 | −$0.07 | +0.00% | $124.2M | SEC |
| Q4 2025 | Feb 26, 2026 | −$0.07 | −$0.04 | +41.69% | $148.5M | SEC |
| Q3 2025 | Oct 29, 2025 | −$0.06 | $0.03 | +150.00% | $151.7M | SEC |
| Q2 2025 | Jul 31, 2025 | −$0.11 | −$0.19 | −67.70% | $156.8M | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.07 | −$0.10 | −45.77% | $149.9M | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.09 | $0.01 | +110.72% | $183.6M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.09 | $0.03 | +132.15% | $173.6M | SEC |
| Q2 2024 | Aug 7, 2024 | −$0.10 | −$0.01 | +89.47% | $182.2M | SEC |
| Q1 2024 | May 7, 2024 | −$0.10 | −$0.12 | −25.79% | $173.7M | SEC |
| Q4 2023 | Feb 27, 2024 | −$0.10 | −$0.09 | +10.00% | $181.9M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.10 | −$0.11 | −10.00% | $178.6M | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.07 | −$0.03 | +58.16% | $265.4M | SEC |
| Q1 2023 | May 3, 2023 | −$0.08 | −$0.02 | +73.92% | $237.6M | SEC |
| Q4 2022 | Feb 23, 2023 | −$0.11 | −$0.11 | +1.52% | $185.4M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.08 | −$0.11 | −30.95% | $179.7M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.01 | −$0.14 | −1850.00% | $309.9M | SEC |
| Q1 2022 | May 9, 2022 | −$0.06 | −$0.08 | −42.86% | $329.2M | SEC |
| Q4 2021 | Feb 24, 2022 | −$0.02 | −$0.11 | −450.00% | $401.3M | SEC |
| Q3 2021 | Oct 28, 2021 | −$0.01 | $0.04 | +500.00% | $385.8M | SEC |
Quarterly revenue
Frequently asked questions
When did OPKO Health (OPK) last report earnings?
OPKO Health last reported on Jul 27, 2026, covering fiscal Q2 2026.
Did OPK beat earnings estimates?
Yes. OPKO Health reported EPS of −$0.01 for Q2 2026 against a −$0.08 estimate — a 87.50% beat.
How much revenue did OPK report last quarter?
OPKO Health reported $163.5M in revenue for Q2 2026, against a consensus estimate of $131.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.